Dr. Li completed his Ph.D. at Mount Sinai School of Medicine (New York), postdoctoral at Whitehead Inst./MIT(Massachusetts Institute of Tech.), fellowship at Harvard. He published 154 peer-reviewed articles with 11007 citations, in journals such as PNAS & JBC, including 20 USPTA-issued patents. His research consists of cancer stem cells; iPSC; brain tumor; ex vivo, in vitro, in vivo model; cancer genome, single-cell transcriptome; tumor microenvironment. He taught as adjunct professor at CSUF and CSUCI. He has an extensive record of national service, serving on the editorial board of Am. J. Pathol., Curr. Stem Cell Res. & Ther. (Section Editor), World J. Stem Cells (Editor-in-Chief), PLOS ONE (Academic Editor), Quantitative imaging in medicine and surgery, Med. Sci. (Basel, Switzerland), Cells (Basel, Switzerland), Biomolecules (Basel, Switzerland) (guest Editor, Special Issue), Frontiers in Oncology (Switzerland), and with the membership of ACTS, ISSCR, SfN, ASCB, ASIP, Royal Society of Medicine (elected overseas fellow), and Royal Society of Biology (fellow).